EcoDrugPlus

Tryptophan Hydroxylase 1b

Ensembl ID : ENSDARG00000036082
Gene Symbol: TPH1B
5 Cross references
177 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSDARG00000041361
Gene Symbol: TTK
5 Cross references
205 Possible Orthologues:

Tubulin, Alpha 7 Like

Ensembl ID : ENSDARG00000104643
Gene Symbol: TUBA7L
25 Enzyme and pathways 5 Cross references
221 Possible Orthologues:

Tubulin, Alpha 8 Like 2

Ensembl ID : ENSDARG00000031164
Gene Symbol: TUBA8L2
42 Enzyme and pathways 5 Cross references
155 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSDARG00000053066
Gene Symbol: TUBB1
28 Enzyme and pathways 5 Cross references
184 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSDARG00000039522
Gene Symbol: TUBB2
25 Enzyme and pathways 5 Cross references
301 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSDARG00000037997
Gene Symbol: TUBB5
19 Enzyme and pathways 5 Cross references
302 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSDARG00000104801
Gene Symbol: TUBB6
28 Enzyme and pathways 5 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSDARG00000035559
Gene Symbol: TP53
46 Enzyme and pathways 5 Cross references
164 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSDARG00000039077
Gene Symbol: TYR
3 Enzyme and pathways 5 Cross references
203 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSDARG00000030621
Gene Symbol: TH
4 Enzyme and pathways 5 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSDARG00000020326
Gene Symbol: TYK2
15 Enzyme and pathways 5 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).